EUVIMED · CrossrefJournal
healthbook TIMES Oncology Hematology
ISSN 2673-2092 · The Heathbook company AG
Latest articles
New Standards and Emerging Strategies in Genitourinary Oncology
Unmet Medical Needs in Metastatic HER2-Positive Breast Cancer
Frontline Fixed-Duration Acalabrutinib Plus Venetoclax in Rapidly Progressive IGHV-Mutated CLL: A Case Report
Establishing a Geriatric Oncology Service in a Medium-Sized Swiss Hospital: Preliminary Results from the PRO-PAC Registry Study
Advances in the Treatment of Newly Diagnosed Multiple Myeloma: Current Status and Future Directions
Emerging Role of Oxidized Phospholipids in Tumor Biology
Practical Experience with Automated Technologies in Anti-CD19 CAR T-Cell Product Manufacturing
Hormone Replacement Therapy After Endometrial Cancer: Current Evidence and Treatment Recommendations
High-Dose Chemotherapy and Stem Cell Transplantation in ZBTB16::RARA Acute Promyelocytic Leukemia: A Case Report
Antibody-Drug Conjugate Sequencing in Metastatic Breast Cancer
The Emerging Role of Oral SERDs in Early Breast Cancer
Bridge the Gap to CAR: Bridging Therapy in CAR T-Cell Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
PARP Inhibition as an Effective Therapeutic Strategy in Disseminated TNBC with Extensive CNS Metastases: A Case Report
Advancements in the Treatment of High-Risk Smoldering Myeloma: News from ASH 2024
A Bright Future for Immunotherapy: CAR T-Cell Therapy Promises Revolutionary Changes
Immune Checkpoint Inhibitors in Frail Older Patients: A Review of Current Evidence
Advances in Breast Cancer Research: Insights from SABCS 2024
Latest Advances in Treatment of Lymphoproliferative Disorders: Key Highlights from ASH 2024
Capivasertib After Progression on CDK4/6 Inhibitor Combined with Endocrine Therapy in a Patient with HR-Positive, HER2-Negative Metastatic Breast Cancer: A Case Report
Immunotherapy and Tumor Heterogeneity in Advanced Goblet Cell Adenocarcinoma of the Appendix: A Case Report
Immunotherapy in Multiple Myeloma: Recent Developments in Monoclonal Antibodies, Bispecifics and Antibody-Drug Conjugates
PSMA-Targeting Radioligand Therapy in Prostate Cancer
Pirtobrutinib for the Treatment of B-Cell Malignancies: Recent Developments
Current Practice in Urogenital Cancer Treatment
Effect of Acalabrutinib in Combination with Bendamustine plus Rituximab on Survival Endpoints in Older Patients with Mantle Cell Lymphoma: Insights from the ECHO Trial
Direct Oral Anticoagulants in Cancer Patients
The Rapidly Evolving Treatment Landscape in Newly Diagnosed Multiple Myeloma: Current Status and Future Directions
https://onco-hema.healthbooktimes.org/article/125802-personalized-organoid-based-treatments-in-older-patients-with-cancer-a-registry-study-in-progress
Advanced Melanoma: Updated Results from Ongoing Trials
Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer Treatment: Insights from the TOPAZ-1 Trial
EUVIMED